Eurobio

Eurobio Scientific is a well-established, revenue-generating French biotechnology company with a core business in diagnostics and life sciences. It develops, manufactures, and distributes a broad portfolio of diagnostic kits and reagents, particularly for infectious diseases (including COVID-19), HLA typing for transplantation, oncology, and autoimmune disorders. The company leverages its internal production capabilities and a direct e-commerce platform to serve clinical laboratories and research institutions. Its strategic focus on high-margin specialty diagnostics and a diversified product catalog underpins its market position in Europe.

Integrated multi-modal diagnostic development and manufacturing platform encompassing molecular biology (PCR), immuno-assay (ELISA), HLA typing, microbiology, and point-of-care testing.

Eurobio operates in the highly competitive in-vitro diagnostics market, competing against multinational giants like Roche, Abbott, bioMérieux, and Siemens Healthineers, as well as numerous other specialty diagnostic firms. Its competitive edge lies in its niche expertise in HLA typing, its integrated manufacturing, and its position as a French/European supplier, which may provide a strategic advantage in its home market.